Adaptive Biotechnologies Corp (ADPT) Volatility At 6.58%, Should You Add A Position?

Adaptive Biotechnologies Corp (NASDAQ: ADPT) is -25.10% lower on its value in year-to-date trading and has touched a low of $2.61 and a high of $10.38 in the current 52-week trading range. The question becomes, what are the chances the stock will make a comeback and enjoy potential growth. Why not look at analysts view on what the future holds for the stock. The ADPT stock was last observed hovering at around $3.57 in the last trading session, with the day’s gains setting it 0.1%.

Currently trading at $3.67, the stock is -9.17% and -17.76% below its SMA20 and SMA50 respectively. However, with a daily trading volume of 1.25 million and changing 2.80% at the moment leaves the stock -36.51% off its SMA200. ADPT registered -61.89% loss for a year compared to 6-month loss of -43.45%. The firm has a 50-day simple moving average (SMA 50) of $1.46 and a 200-day simple moving average (SMA200) of -$1.64.

Invest Like Buffett: Travel Back in Time & Grab This High-Potential Stock Before It Explodes

Imagine buying Apple for $1, Amazon for $2, or Tesla for $3. Now, imagine the same opportunity with a hidden gem trading under $3 right now.

Our premium newsletter, powered by AI and expert analysis, uncovers these time-travel investment opportunities.

Invest like Buffett and profit from undervalued gems before the market catches on.

Limited-time offer: Get your first month for just $2.90 and start your journey to wealth creation.


The stock witnessed a -21.08% gain in the last 1 month and extending the period to 3 months gives it a -23.86%, and is -1.87% down over the last 5 days. If we measure the stock’s price variations over the week and the month, we find that the volatility rates stand at 6.58% over the week and 6.72% over the month.

Adaptive Biotechnologies Corp (ADPT) has around 790 employees, a market worth around $531.31M and $179.69M in sales. Profit margin for the company is -109.04%. Distance from 52-week low is 40.88% and -64.64% from its 52-week high. The company has generated returns on investments over the last 12 months (-33.77%).

Adaptive Biotechnologies Corp quarterly earnings per share for the current quarter are estimated at -$0.3 with sales reaching $48.46M over the same period.The EPS is expected to grow by 1.32% this year, but quarterly earnings will post -6.70% year-over-year. Quarterly sales are estimated to shrink -12.20% in year-over-year returns.

291 institutions hold shares in Adaptive Biotechnologies Corp (ADPT), with institutional investors hold 99.13% of the company’s shares. The shares outstanding are 143.11M, and float is at 141.49M with Short Float at 6.19%. Institutions hold 97.37% of the Float.

The top institutional shareholder in the company is Viking Global Investors, L.P. with over 29.99 million shares valued at $201.26 million. The investor’s holdings represent 20.74% of the ADPT Shares outstanding. As of Jun 29, 2023, the second largest holder is Vanguard Group Inc with 12.05 million shares valued at $80.87 million to account for 8.33% of the shares outstanding. The other top investors are Matrix Capital Management which holds 11.57 million shares representing 8.00% and valued at over $77.65 million, while ARK Investment Management, LLC holds 7.96% of the shares totaling 11.51 million with a market value of $62.73 million.

Adaptive Biotechnologies Corp (ADPT) Insider Activity

A total of 1 insider transactions have happened at Adaptive Biotechnologies Corp (ADPT) in the last six months, with sales accounting for 1 and purchases happening 0 times. The most recent transaction is an insider sale by PISKEL KYLE, the company’s Principal Accounting Officer. SEC filings show that PISKEL KYLE sold 259 shares of the company’s common stock on Nov 16 at a price of $4.13 per share for a total of $1070.0. Following the sale, the insider now owns 87305.0 shares.

Adaptive Biotechnologies Corp disclosed in a document filed with the SEC on Aug 08 that SOOD NITIN (Chief Commercial Officer, MRD) sold a total of 10,550 shares of the company’s common stock. The trade occurred on Aug 08 and was made at $6.54 per share for $68997.0. Following the transaction, the insider now directly holds 0.21 million shares of the ADPT stock.

Still, SEC filings show that on Aug 07, SOOD NITIN (Chief Commercial Officer, MRD) disposed off 5,652 shares at an average price of $6.78 for $38321.0. The insider now directly holds 225,358 shares of Adaptive Biotechnologies Corp (ADPT).

Adaptive Biotechnologies Corp (ADPT): Who are the competitors?

One of the company’s main competitors (and peers) include Legend Biotech Corp. ADR (LEGN) that is trading 18.75% up over the past 12 months.Twist Bioscience Corp. (TWST) lies in the list of competitors of the Adaptive Biotechnologies Corp and is 54.05% higher over the same period from ADPTI-Mab ADR (IMAB) is -64.69% down on the 1-year trading charts.